<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 09:52:43 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result1_attr1">WHITE BLOOD CELL COUNT</td><td>7.5</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result1_attr2">RED BLOOD CELL COUNT</td><td>4.61</td><td>3.80-5.10 Million/uL</td><td/></tr><tr><td ID="result1_attr3">HEMOGLOBIN</td><td>13.0</td><td>11.7-15.5 g/dL</td><td/></tr><tr><td ID="result1_attr4">HEMATOCRIT</td><td>41.5</td><td>35.0-45.0 %</td><td/></tr><tr><td ID="result1_attr5">MCV</td><td>90.0</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result1_attr6">MCH</td><td>28.2</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result1_attr7">MCHC</td><td>31.3</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result1_attr8">RDW</td><td>13.2</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result1_attr9">PLATELET COUNT</td><td>250</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result1_attr10">MPV</td><td>11.0</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result1_attr11">ABSOLUTE NEUTROPHILS</td><td>4208</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result1_attr12">ABSOLUTE LYMPHOCYTES</td><td>2708</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result1_attr13">ABSOLUTE MONOCYTES</td><td>443</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result1_attr14">ABSOLUTE EOSINOPHILS</td><td>113</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result1_attr15">ABSOLUTE BASOPHILS</td><td>30</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result1_attr16">NEUTROPHILS</td><td>56.1</td><td/><td/></tr><tr><td ID="result1_attr17">LYMPHOCYTES</td><td>36.1</td><td/><td/></tr><tr><td ID="result1_attr18">MONOCYTES</td><td>5.9</td><td/><td/></tr><tr><td ID="result1_attr19">EOSINOPHILS</td><td>1.5</td><td/><td/></tr><tr><td ID="result1_attr20">BASOPHILS</td><td>0.4</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 09:52:13 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-Tampa
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result2_attr1">GLUCOSE</td><td>83</td><td>65-99 mg/dL</td><td ID="result2_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result2_attr2">UREA NITROGEN (BUN)</td><td>14</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result2_attr3">CREATININE</td><td>0.74</td><td>0.50-1.05 mg/dL</td><td/></tr><tr><td ID="result2_attr4">EGFR</td><td>88</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result2_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result2_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result2_attr6">SODIUM</td><td>139</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result2_attr7">POTASSIUM</td><td>3.4</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result2_attr8">CHLORIDE</td><td>103</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result2_attr9">CARBON DIOXIDE</td><td>29</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result2_attr10">CALCIUM</td><td>9.5</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td ID="result2_attr11">PROTEIN, TOTAL</td><td>6.4</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result2_attr12">ALBUMIN</td><td>4.0</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result2_attr13">GLOBULIN</td><td>2.4</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result2_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.7</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result2_attr15">BILIRUBIN, TOTAL</td><td>0.9</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result2_attr16">ALKALINE PHOSPHATASE</td><td>65</td><td>37-153 U/L</td><td/></tr><tr><td ID="result2_attr17">AST</td><td>17</td><td>10-35 U/L</td><td/></tr><tr><td ID="result2_attr18">ALT</td><td>13</td><td>6-29 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">VITAMIN D,25-OH,TOTAL,IA (17306)</span><br/>Reviewed date:[REDACTED] 09:52:52 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-Tampa
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result3_attr1">VITAMIN D,25-OH,TOTAL,IA</td><td>58</td><td>30-100 ng/mL</td><td ID="result3_attr1_notes"><p>Vitamin D Status         25-OH Vitamin D:</p><p>Deficiency:                    &lt;20 ng/mL</p><p>Insufficiency:             20 - 29 ng/mL</p><p>Optimal:                 &gt; or = 30 ng/mL</p><p>For 25-OH Vitamin D testing on patients on</p><p>D2-supplementation and patients for whom quantitation</p><p>of D2 and D3 fractions is required, the QuestAssureD(TM)</p><p>25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order</p><p>code 92888 (patients &gt;2yrs).</p><p>See Note 1</p><p>Note 1</p><p>For additional information, please refer to</p><p>http://education.QuestDiagnostics.com/faq/FAQ199</p><p>(This link is being provided for informational/</p><p>educational purposes only.)</p></td></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL, STANDARD (7600)</span><br/>Reviewed date:[REDACTED] 09:52:20 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED][REDACTED]<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result4_attr1">CHOLESTEROL, TOTAL</td><td>122</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result4_attr2">HDL CHOLESTEROL</td><td>47</td><td>&gt; OR = 50 mg/dL</td><td/></tr><tr><td ID="result4_attr3">TRIGLYCERIDES</td><td>117</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result4_attr4">LDL-CHOLESTEROL</td><td>55</td><td/><td ID="result4_attr4_notes"><p>Reference range: &lt;100</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>with &gt; or = 2 CHD risk factors.</p><p>LDL-C is now calculated using the [REDACTED]</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>[REDACTED] et al. JAMA. 2013;310(19): [REDACTED]-[REDACTED]</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p></td></tr><tr><td ID="result4_attr5">CHOL/HDLC RATIO</td><td>2.6</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result4_attr6">NON HDL CHOLESTEROL</td><td>75</td><td>&lt;130 mg/dL (calc)</td><td ID="result4_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p></td></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 09:52:06 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result5_attr1">HEMOGLOBIN A1c</td><td>5.1</td><td>&lt;5.7 % of total Hgb</td><td ID="result5_attr1_notes"><p>For the purpose of screening for the presence of</p><p>diabetes:</p><p>&lt;5.7%       Consistent with the absence of diabetes</p><p>5.7-6.4%    Consistent with increased risk for diabetes</p><p>            (prediabetes)</p><p>&gt; or =6.5%  Consistent with diabetes</p><p>This assay result is consistent with a decreased risk</p><p>of diabetes.</p><p>Currently, no consensus exists regarding use of</p><p>hemoglobin A1c for diagnosis of diabetes in children.</p><p>According to American Diabetes Association (ADA)</p><p>guidelines, hemoglobin A1c &lt;7.0% represents optimal</p><p>control in non-pregnant diabetic patients. Different</p><p>metrics may apply to specific patient populations.</p><p>Standards of Medical Care in Diabetes(ADA).</p><p>This test was performed on the Roche cobas c503 platform.</p><p>Effective [REDACTED], a change in test platforms from the</p><p>[REDACTED] Architect to the Roche cobas c503 may have shifted</p><p>HbA1c results compared to historical results.</p><p>Based on laboratory validation testing conducted at</p><p>Quest, the Roche platform relative to the [REDACTED]</p><p>platform had an average increase in HbA1c value of</p><p>&lt; or = 0.3%. This difference is within accepted</p><p>variability established by the National Glycohemoglobin</p><p>Standardization Program. Note that not all individuals</p><p>will have had a shift in their results and direct</p><p>comparisons between historical and current results for</p><p>testing conducted on different platforms is not</p><p>recommended.</p></td></tr><tr><td colspan="4"><span class="content_span">VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>Reviewed date:[REDACTED] 09:51:53 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED][REDACTED]<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result6_attr1">VITAMIN B12</td><td>299</td><td>200-1100 pg/mL</td><td ID="result6_attr1_notes"><p/><p>Please Note: Although the reference range for vitamin</p><p>B12 is 200-1100 pg/mL, it has been reported that between</p><p>5 and 10% of patients with values between 200 and 400</p><p>pg/mL may experience neuropsychiatric and hematologic</p><p>abnormalities due to occult B12 deficiency; less than 1%</p><p>of patients with values above 400 pg/mL will have symptoms.</p></td></tr><tr><td ID="result6_attr2">FOLATE, SERUM</td><td>7.2</td><td/><td ID="result6_attr2_notes"><p>                           Reference Range</p><p>                           Low:           &lt;3.4</p><p>                           Borderline:    3.4-5.4</p><p>                           Normal:        &gt;5.4</p></td></tr><tr><td colspan="4"><span class="content_span">TSH+FREE T4 (58984)</span><br/>Reviewed date:[REDACTED] 09:51:44 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-Tampa
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result7_attr1">TSH</td><td>1.30</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td ID="result7_attr2">T4, FREE</td><td>1.1</td><td>0.8-1.8 ng/dL</td><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Acute diverticulitis with perforation of sigmoid colon | [REDACTED] or [REDACTED] </td></tr><tr><th>Diagnosis 1</th><td>Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding (K57.80)</td></tr><tr><th>Referral Organization</th><td>[REDACTED] Healthcare of Brevard</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Nurse Practitioner</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>General Surgery</td></tr><tr><th>Referral Priority</th><td>Urgent</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>PLEASE EVAL AND TREAT </td></tr><tr><th>Diagnosis 1</th><td>Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding (K57.80)</td></tr><tr><th>Referral Organization</th><td>[REDACTED] Healthcare of Brevard</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>General Surgery</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Ondansetron HCl 4 MG</td><td ID="instruction1"><p>1 tablet Orally Once a day for 30 days</p><p>As needed</p></td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication2">Atorvastatin Calcium 20 MG</td><td ID="instruction2">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Omeprazole 20 MG</td><td ID="instruction3">1 capsule 30 minutes before morning meal Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Baclofen 10 MG</td><td ID="instruction4"><p>1 tablet as needed Orally Twice a day for 90 days</p><p>As needed</p></td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Valsartan-hydroCHLOROthiazide 160-12.5 MG</td><td ID="instruction5">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Xarelto 20 MG</td><td ID="instruction6">1 tablet with food Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Gabapentin 100 MG</td><td ID="instruction7">3 capsule at bedtime Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div>No Information</div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Former Smoker</td><td>NA - [REDACTED]</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Female</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>former smoker</td><td/></tr><tr><td>When did you stop smoking?</td><td>[REDACTED]</td><td/></tr></tbody></table><span class="content_span">Tobacco use other than smoking:</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Are you an other tobacco user?</td><td>No</td><td/></tr></tbody></table><span class="content_span">OPIOID Risk Tool (2018 Edition)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Family Hx Alcohol?</td><td>No</td><td/></tr><tr><td>Family Hx Illegal Drugs?</td><td>No</td><td/></tr><tr><td>Family Hx Rx Drugs?</td><td>No</td><td/></tr><tr><td>Personal Hx Alcohol?</td><td>No</td><td/></tr><tr><td>Personal Hx Illegal Drugs?</td><td>No</td><td/></tr><tr><td>Personal Hx Rx Drugs?</td><td>No</td><td/></tr><tr><td>Age between [REDACTED]-[REDACTED] years?</td><td>No</td><td/></tr><tr><td>History of Preadolescent Sexual Abuse?</td><td>No</td><td/></tr><tr><td>TOTAL SCORE</td><td>0</td><td/></tr><tr><td>Risk Level for Opioid Use</td><td>low</td><td/></tr></tbody></table><span class="content_span">AUDIT-C (Standard)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table><span class="content_span">DAST-10 (2021 Edition)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>1. Have you used drugs other than those required for medical reasons?</td><td>No</td><td/></tr><tr><td>2. Do you abuse more than one drug at a time?</td><td>No</td><td/></tr><tr><td>3. Are you always able to stop using drugs when you want to?</td><td>Yes</td><td/></tr><tr><td>4. Have you had \"blackouts\" or \"flashbacks\" as a result of drug use?</td><td>No</td><td/></tr><tr><td>5. Do you ever feel bad or guilty about your drug use?</td><td>No</td><td/></tr><tr><td>6. Does your spouse (or parents) ever complain about your involvement with drugs?</td><td>No</td><td/></tr><tr><td>7. Have you neglected your family because of your use of drugs?</td><td>No</td><td/></tr><tr><td>8. Have you engaged in illegal activities in order to obtain drugs?</td><td>No</td><td/></tr><tr><td>9. Have you ever experienced withdrawal symptoms (felt sick) when you stopped taking drugs?</td><td>No</td><td/></tr><tr><td>10. Have you had medical problems as a result of your drug use (e.g., memory loss, hepatitis, convulsions, bleeding etc.)?</td><td>No</td><td/></tr><tr><td>Results:</td><td>0</td><td/></tr><tr><td>Interpretation of Score:</td><td>No problems reported</td><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Hereditary coagulation factor deficiency (16922007)</td><td ID="Problem1">Hereditary deficiency of other clotting factors (D68.2)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Thrombophilia (234467004)</td><td ID="Problem2">Other thrombophilia (D68.69)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Mixed hyperlipidemia (267434003)</td><td ID="Problem3">Mixed hyperlipidemia (E78.2)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>191813001</td><td ID="Problem4">Alcohol dependence, in remission (F10.21)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>191611001</td><td ID="Problem5">Major depressive disorder, recurrent, moderate (F33.1)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>46244001</td><td ID="Problem6">Major depressive disorder, recurrent, in full remission (F33.42)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Essential hypertension (59621000)</td><td ID="Problem7">Essential (primary) hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Perforation of large and small intestine due to diverticulitis (1086441000119100)</td><td ID="Problem8">Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding (K57.80)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Fibromyalgia (203082005)</td><td ID="Problem9">Fibromyalgia (M79.7)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td/><td ID="Problem10">Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter (T50.905A)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>711150003</td><td ID="Problem11">Long term (current) use of anticoagulants (Z79.01)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>59621000</td><td ID="Problem12">Primary hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems12notes">continue Valsartan-hydroCHLOROthiazide 320-12.5 MG Tablet 1 tablet Orally Once a day</td></tr><tr><td>Problem</td><td>Vitamin D deficiency (34713006)</td><td ID="Problem13">Vitamin D deficiency (E55.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Diverticular disease of colon (398050005)</td><td ID="Problem14">Diverticulosis (K57.90)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>266435005</td><td ID="Problem15">Gastroesophageal reflux disease without esophagitis (K21.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Chronic fatigue syndrome (52702003)</td><td ID="Problem16">Chronic fatigue (R53.82)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>711150003</td><td ID="Problem17">Anticoagulant long-term use (Z79.01)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems17notes">on Xarelto</td></tr><tr><td>Problem</td><td>Recurrent major depression (66344007)</td><td ID="Problem18">Episode of recurrent major depressive disorder, unspecified depression episode severity (F33.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Rheumatoid arthritis (69896004)</td><td ID="Problem19">Rheumatoid arthritis involving multiple sites, unspecified whether rheumatoid factor present (M06.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Polyneuropathy (42345000)</td><td ID="Problem20">Neuropathy due to medical condition (G63)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems20notes">Gabapentin 100 MG Capsule 3 capsule at bedtime Orally Once a day.</td></tr><tr><td>Problem</td><td>429098002</td><td ID="Problem21">Chronic thromboembolism of deep vein of lower extremity, unspecified laterality (I82.509)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems21notes">Patient on Xarelto 20 MG Tablet 1 tablet with food Orally Once a day.</td></tr><tr><td>Problem</td><td>307091009</td><td ID="Problem22">Factor V Leiden (D68.51)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>32914008</td><td ID="Problem23">RLS (restless legs syndrome) (G25.81)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>26538006</td><td ID="Problem24">Degenerative disc disease, lumbar (M51.36)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>66590003</td><td ID="Problem25">Alcohol dependence with uncomplicated withdrawal (F10.230)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>82 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital2">Temperature</th><td>97.4 degrees Fahrenheit</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital3">Respiratory Rate</th><td>20 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital4">Oximetry</th><td>99 %</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital5">Blood pressure diastolic</th><td>82 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital6">Weight-kg</th><td>56.15 kg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital7">Height</th><td>63 in</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital8">Blood pressure systolic</th><td>123 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital9">Weight</th><td>123.8 lbs</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital10">BMI</th><td>21.93 kg/m2</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Primary hypertension I10 ; Diverticulosis K57.90 ; Gastroesophageal reflux disease without esophagitis K21.9 ; Neuropathy due to medical condition G63 ; Chronic thromboembolism of deep vein of lower extremity, unspecified laterality I82.509 ; Fibromyalgia M79.7 ; Factor V Leiden D68.51 ; Degenerative disc disease, lumbar M51.36 ; RLS (restless legs syndrome) G25.81 ; Rheumatoid arthritis involving multiple sites, unspecified whether rheumatoid factor present M06.9 ; Other thrombophilia D68.69 ; Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter T50.905A ; Episode of recurrent major depressive disorder, unspecified depression episode severity F33.9 ; Anticoagulant long-term use Z79.01 ; Alcohol dependence with uncomplicated withdrawal F10.230 ; BMI 24.0-24.9, adult Z68.24 ; Mixed hyperlipidemia E78.2 ; Impaired fasting glucose R73.01 ; Vitamin D deficiency E55.9 and Vitamin B deficiency E53.9</td></tr><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Primary hypertension I10 ; Diverticulosis K57.90 ; Factor V Leiden D68.51 ; Degenerative disc disease, lumbar M51.36 ; RLS (restless legs syndrome) G25.81 ; Fibromyalgia M79.7 ; Gastroesophageal reflux disease without esophagitis K21.9 ; Rheumatoid arthritis involving multiple sites, unspecified whether rheumatoid factor present M06.9 ; Other thrombophilia D68.69 ; Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter T50.905A ; Episode of recurrent major depressive disorder, unspecified depression episode severity F33.9 ; Neuropathy due to medical condition G63 ; Anticoagulant long-term use Z79.01 ; Chronic thromboembolism of deep vein of lower extremity, unspecified laterality I82.509 ; Alcohol dependence with uncomplicated withdrawal F10.230 ; Mixed hyperlipidemia E78.2 and Vitamin D deficiency E55.9</td></tr><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Diverticulosis K57.90</td></tr><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Primary hypertension I10 ; Mixed hyperlipidemia E78.2 ; Vitamin D deficiency E55.9 ; Diverticulosis K57.90 ; Chronic fatigue R53.82 ; Vitamin B12 deficiency E53.8 ; Impaired fasting glucose R73.01 ; Factor V Leiden D68.51 ; Neuropathy due to medical condition G63 and Alcohol dependence with uncomplicated withdrawal F10.230</td></tr><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Rheumatoid arthritis involving multiple sites, unspecified whether rheumatoid factor present M06.9 ; Neuropathy due to medical condition G63 ; Chronic thromboembolism of deep vein of lower extremity, unspecified laterality I82.509 ; Major depressive disorder, recurrent, in full remission F33.42 ; Alcohol dependence, in remission F10.21 ; Encounter for screening for depression Z13.31 ; Body mass index [BMI] 21.0-21.9, adult Z68.21 ; Essential (primary) hypertension I10 ; Hereditary deficiency of other clotting factors D68.2 and Long term (current) use of anticoagulants Z79.01</td></tr><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity I82.509</td></tr><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED] Healthcare of Brevard</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Factor V Leiden D68.51</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Primary hypertension (ICD-10 - I10)</td><td/><td>Continue Valsartan HCTZ as prescribed. Discussed DASH diet and increasing daily physical activity. Pt voices understanding.</td><td>.</td></tr><tr><td ID="ref2">[REDACTED]</td><td>Diverticulosis (ICD-10 - K57.90)</td><td/><td>Continue Flagyl, ondansetron, and Cipro as prescribed </td><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity (ICD-10 - I82.509)</td><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Primary hypertension (ICD-10 - I10)</td><td>continue Valsartan-hydroCHLOROthiazide 320-12.5 MG Tablet 1 tablet Orally Once a day</td><td>Continue current plan of care</td><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Diverticulosis (ICD-10 - K57.90)</td><td/><td>Continue to monitor</td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Primary hypertension (ICD-10 - I10)</td><td>continue Valsartan-hydroCHLOROthiazide 320-12.5 MG Tablet 1 tablet Orally Once a day</td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Diverticulosis (ICD-10 - K57.90)</td><td/><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Factor V Leiden (ICD-10 - D68.51)</td><td/><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Rheumatoid arthritis involving multiple sites, unspecified whether rheumatoid factor present (ICD-10 - M06.9)</td><td/><td>Stable [REDACTED] with muscle relaxer and Gabapentin as needed. Pt denies any treatment for RA at this time. Will continue to monitor. </td><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Neuropathy due to medical condition (ICD-10 - G63)</td><td>Gabapentin 100 MG Capsule 3 capsule at bedtime Orally Once a day.</td><td>Stable [REDACTED] with Gabapentin use. Neuropathy likely releated to RA. Pt declines any RA specific treatment at this time. Will continue to monitor. </td><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Chronic thromboembolism of deep vein of lower extremity, unspecified laterality (ICD-10 - I82.509)</td><td>Patient on Xarelto 20 MG Tablet 1 tablet with food Orally Once a day.</td><td>Pt has chronic DVT and is on Xarelto treatment daily. Will continue to monitor. Pt to have US scans as needed for swelling or worsening pain. </td><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td/><td/><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Factor V Leiden (ICD-10 - D68.51)</td><td/><td>Continue to monitor</td><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Gastroesophageal reflux disease without esophagitis (ICD-10 - K21.9)</td><td/><td>Continue omeprazole as prescribed.  Avoid spicy/irritating foods. If smoking or drinking should stop, and if ingesting caffeine should reduce (in all forms) to help decrease symptoms. Take medications as directed. Will continue to monitor and will adjust treatment plan as needed. Pt voiced understanding.</td><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Neuropathy due to medical condition (ICD-10 - G63)</td><td/><td>Continue gabapentin as prescribed </td><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Degenerative disc disease, lumbar (ICD-10 - M51.36)</td><td/><td>Continue current plan of care</td><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Diverticulosis (ICD-10 - K57.90)</td><td/><td>Surgical repair scheduled for [REDACTED]</td><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Major depressive disorder, recurrent, in full remission (ICD-10 - F33.42)</td><td/><td>Doing well at this time without treatment. Pt states depressive symptoms are resolved and does not feel depressed. Will monitor periodically and do PHQ-9 screening at least yearly.</td><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Chronic fatigue (ICD-10 - R53.82)</td><td/><td/><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>RLS (restless legs syndrome) (ICD-10 - G25.81)</td><td/><td>Continue current plan of care</td><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Chronic thromboembolism of deep vein of lower extremity, unspecified laterality (ICD-10 - I82.509)</td><td>Patient on Xarelto</td><td>Continue Xarelto as prewscribed</td><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Alcohol dependence, in remission (ICD-10 - F10.21)</td><td/><td>Pt has been sober since [REDACTED]. Stressed importance of not restarting. Will continue to monitor and will monitor drinking status periodically.</td><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Fibromyalgia (ICD-10 - M79.7)</td><td/><td>Continue Baclofen as prescribed </td><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Fibromyalgia (ICD-10 - M79.7)</td><td/><td>Continue current plan of care</td><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>Vitamin B12 deficiency (ICD-10 - E53.8)</td><td/><td/><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Encounter for screening for depression (ICD-10 - Z13.31)</td><td/><td>PHQ-9 completed as noted above. Will continue to monitor for signs of depression and complete PHQ-9 yearly and as needed.</td><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Body mass index [BMI] 21.0-21.9, adult (ICD-10 - Z68.21)</td><td/><td>Stressed importance of keeping BMI in normal range of [REDACTED]-25. Advised to lose 10% of TBW. Exercise/walk 2-3 x week; read labels; and oriented pt regarding healthy weight and healthy nutritional choices.</td><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Impaired fasting glucose (ICD-10 - R73.01)</td><td/><td/><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>Gastroesophageal reflux disease without esophagitis (ICD-10 - K21.9)</td><td/><td>Continue current plan of care</td><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>Factor V Leiden (ICD-10 - D68.51)</td><td/><td>Will continue to monitor</td><td/></tr><tr><td ID="ref32">[REDACTED]</td><td>Degenerative disc disease, lumbar (ICD-10 - M51.36)</td><td/><td>Contine Baclofen as prescribed. Will continue to monitor</td><td/></tr><tr><td ID="ref33">[REDACTED]</td><td>Rheumatoid arthritis involving multiple sites, unspecified whether rheumatoid factor present (ICD-10 - M06.9)</td><td/><td>Continue current plan of care</td><td/></tr><tr><td ID="ref34">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td>Stable [REDACTED]. Will decrease Valsartan to 160 mg daily and monitor BP. If BP raises, may need to go back to original Valsartan dose. Pt agrees with plan. </td><td/></tr><tr><td ID="ref35">[REDACTED]</td><td>Factor V Leiden (ICD-10 - D68.51)</td><td/><td/><td/></tr><tr><td ID="ref36">[REDACTED]</td><td>Hereditary deficiency of other clotting factors (ICD-10 - D68.2)</td><td/><td>Stable [REDACTED] with current treatment. Pt to continue blood thinner. Will continue to monitor. </td><td/></tr><tr><td ID="ref37">[REDACTED]</td><td>Neuropathy due to medical condition (ICD-10 - G63)</td><td>Gabapentin 100 MG Capsule 3 capsule at bedtime Orally Once a day.</td><td/><td/></tr><tr><td ID="ref38">[REDACTED]</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td/><td>Continue to monitor</td><td/></tr><tr><td ID="ref39">[REDACTED]</td><td>RLS (restless legs syndrome) (ICD-10 - G25.81)</td><td/><td>Continue gabapentin as prescribed</td><td/></tr><tr><td ID="ref40">[REDACTED]</td><td>Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter (ICD-10 - T50.905A)</td><td/><td>Continue to monitor</td><td/></tr><tr><td ID="ref41">[REDACTED]</td><td>Rheumatoid arthritis involving multiple sites, unspecified whether rheumatoid factor present (ICD-10 - M06.9)</td><td/><td>Will continue to monitor</td><td/></tr><tr><td ID="ref42">[REDACTED]</td><td>Alcohol dependence with uncomplicated withdrawal (ICD-10 - F10.230)</td><td/><td/><td/></tr><tr><td ID="ref43">[REDACTED]</td><td>Long term (current) use of anticoagulants (ICD-10 - Z79.01)</td><td/><td>Stable [REDACTED] with current treatment. Will continue to monitor. </td><td/></tr><tr><td ID="ref44">[REDACTED]</td><td>Episode of recurrent major depressive disorder, unspecified depression episode severity (ICD-10 - F33.9)</td><td/><td>Continue current plan of care</td><td/></tr><tr><td ID="ref45">[REDACTED]</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td/><td>Will continue to monitor</td><td/></tr><tr><td ID="ref46">[REDACTED]</td><td>Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter (ICD-10 - T50.905A)</td><td/><td/><td/></tr><tr><td ID="ref47">[REDACTED]</td><td>Neuropathy due to medical condition (ICD-10 - G63)</td><td>Gabapentin 100 MG Capsule 3 capsule at bedtime Orally Once a day.</td><td>Continue current plan of care</td><td/></tr><tr><td ID="ref48">[REDACTED]</td><td>Anticoagulant long-term use (ICD-10 - Z79.01)</td><td>on Xarelto</td><td>Continue current plan of care</td><td/></tr><tr><td ID="ref49">[REDACTED]</td><td>Episode of recurrent major depressive disorder, unspecified depression episode severity (ICD-10 - F33.9)</td><td/><td/><td/></tr><tr><td ID="ref50">[REDACTED]</td><td>Anticoagulant long-term use (ICD-10 - Z79.01)</td><td>on Xarelto</td><td>Will continue to monitor</td><td/></tr><tr><td ID="ref51">[REDACTED]</td><td>Chronic thromboembolism of deep vein of lower extremity, unspecified laterality (ICD-10 - I82.509)</td><td>Patient on Xarelto 20 MG Tablet 1 tablet with food Orally Once a day.</td><td>Continue current plan of care</td><td/></tr><tr><td ID="ref52">[REDACTED]</td><td>Alcohol dependence with uncomplicated withdrawal (ICD-10 - F10.230)</td><td/><td>Continue to monitor</td><td/></tr><tr><td ID="ref53">[REDACTED]</td><td>Alcohol dependence with uncomplicated withdrawal (ICD-10 - F10.230)</td><td/><td>Discussed the dangers of alcohol and addiction. Recommended pt to decrease alcohol intake to reduce risk of complications such as falling. </td><td/></tr><tr><td ID="ref54">[REDACTED]</td><td>BMI 24.0-24.9, adult (ICD-10 - Z68.24)</td><td/><td/><td/></tr><tr><td ID="ref55">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>Continue current plan of care</td><td/></tr><tr><td ID="ref56">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td/><td>Continue current plan of care</td><td/></tr><tr><td ID="ref57">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td/></tr><tr><td ID="ref58">[REDACTED]</td><td>Impaired fasting glucose (ICD-10 - R73.01)</td><td/><td/><td/></tr><tr><td ID="ref59">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td/><td/><td/></tr><tr><td ID="ref60">[REDACTED]</td><td>Vitamin B deficiency (ICD-10 - E53.9)</td><td/><td/><td>labs due [REDACTED], faxed to quest</td></tr><tr><td ID="ref61">[REDACTED]</td><td>Other</td><td/><td/><td>Labs faxed to Quest on Malabar rd -SP</td></tr><tr><td ID="ref62">[REDACTED]</td><td>Other</td><td/><td>Due to chronic DVT and Factor V [REDACTED], pt to continue with Xarelto treatment. Advised pt to monitor for excessive/uncontrolled bleeding and educated on when to come to the clinic vs going to the local ED. Pt voiced understanding.</td><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">CT Scan : Abdomen, with contrast</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">Vitamin B12 and Folate</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">Vitamin B12 and Folate</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">Vitamin B12 and Folate</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest5">Hemoglobin A1c</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest6">Hemoglobin A1c</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest7">CBC With Differential/Platelet</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest8">CBC With Differential/Platelet</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest9">CBC With Differential/Platelet</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest10">Vitamin D, 25-Hydroxy</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest11">Vitamin D, 25-Hydroxy</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest12">Vitamin D, 25-Hydroxy</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest13">TSH+Free T4</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest14">TSH+Free T4</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest15">TSH+Free T4</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest16">Lipid Panel With LDL/HDL Ratio</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest17">Lipid Panel With LDL/HDL Ratio</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest18">Lipid Panel</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest19">cmp</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest20">cmp</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest21">cmp</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest22">CT Abdomen and Pelvis</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest23">MAMMOGRAM, SCREENING</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest24">DEXA Hip and Spine</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest25">Vitamin B12 and Folate-000810</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest26">Hemoglobin A1c-001453</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest27">Magnesium-001537</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest28">TSH-004259</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest29">CBC With Differential/Platelet-005009</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest30">Rheumatoid Factor (RF)-006502</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest31">Vitamin D, 25-Hydroxy-081950</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest32">Comp. Metabolic Panel (14)-322000</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest33">UA/M w/rflx Culture, Comp-377200</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest34">Fe+TIBC+Fer-030825</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest35">Lipid Panel and Chol/HDL Ratio-235012</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>CarePlus Healthcare</td><td>PO BOX 14697 [REDACTED]-4600</td><td>[REDACTED]</td><td>619177201</td><td/><td>[REDACTED]</td><td>Self - patient is the insured</td><td/><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>fibromyalgia</td><td/></tr><tr><td>rheumatoid arthritis</td><td/></tr><tr><td>hypertension</td><td/></tr><tr><td>Recurrent Blood Clots</td><td/></tr><tr><td>Mammo 2021, Colonoscopy 2021, DEXA 2021, AVW [REDACTED]</td><td/></tr><tr><td>Diverticulitis</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>cholecystectomy</td><td/></tr><tr><td>Gallbladder removed</td><td/></tr><tr><td>left elbow tendon debridement</td><td/></tr><tr><td>Left elbow-tendon debridement</td><td/></tr><tr><td>hysterectomy-total</td><td/></tr><tr><td>Total Hysterectomy</td><td/></tr><tr><td>Moh's Surgery-R side of nose</td><td/></tr><tr><td>Mon's surgery- right side of nose</td><td/></tr></tbody></table><span class="content_span">Hospitalization History</span><table width="100%" border="1"><thead><tr><th>Reason</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>Diverticulitis</td><td>10/2023</td></tr><tr><td>as above</td><td/></tr><tr><td>elevated INR</td><td/></tr><tr><td>gross hematuria</td><td/></tr><tr><td>pyelonephritis</td><td>10/22</td></tr></tbody></table></div><br/><br/>
</body></html>